92 related articles for article (PubMed ID: 2510987)
1. [Adaptation of the body to alkylating anti-tumor substances].
Kulik GI; Pel'kis FP; Korol' VI
Eksp Onkol; 1989; 11(6):34-8. PubMed ID: 2510987
[TBL] [Abstract][Full Text] [Related]
2. [Hormonal sensitivity of mammary adenocarcinoma in rats and the capacity of the sulfhydryl groups of this tumor for bindig by various antineoplastic drugs].
Vasnetsova SS; Kulik GI; Korol' VI; Turkevich NM
Vopr Onkol; 1977; 23(5):91-4. PubMed ID: 888422
[TBL] [Abstract][Full Text] [Related]
3. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
Kulik GI
Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
[No Abstract] [Full Text] [Related]
4. [Effect of alkylating antitumour preparations on the blood serum SH-groups under clinical and experimental conditions].
Kulik GI; Danilenko LP
Vrach Delo; 1966 Sep; 9():87-9. PubMed ID: 6001283
[No Abstract] [Full Text] [Related]
5. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
6. [Modification of the toxic effects of cis-dichlorodiammineplatinum].
Kulik GI; Chekhun VF; Pel'kis FP; Korol' VI; Boĭm TM
Eksp Onkol; 1985; 7(6):55-8. PubMed ID: 4085400
[TBL] [Abstract][Full Text] [Related]
7. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
8. [Genetic differences in mice in the sensitivity to the immunodepressive action of alkylating agents].
Kim NI; Telegin LIu; Pevnitskiĭ LA
Biull Eksp Biol Med; 1983 Apr; 95(4):79-81. PubMed ID: 6403076
[TBL] [Abstract][Full Text] [Related]
9. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.
Teicher BA; Herman TS; Holden SA; Wang YY; Pfeffer MR; Crawford JW; Frei E
Science; 1990 Mar; 247(4949 Pt 1):1457-61. PubMed ID: 2108497
[TBL] [Abstract][Full Text] [Related]
10. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
11. [Effect of thiophosphamide on SH-groups of structural and soluble proteins of Guerin's carcinoma and of its drug-resistant variants].
Kulik GI
Farmakol Toksikol; 1970; 33(4):476-9. PubMed ID: 5004874
[No Abstract] [Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
13. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
Chang TK; Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity of cytostatics on a newly transplanted tumor in mice, myosarcoma ISM].
Karaivanova MKh
Eksp Med Morfol; 1978; 17(2):72-5. PubMed ID: 658001
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
Schmid FA; Otter GM; Mehta BM
Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Scopolamine Hydrobromide Trihydrate (CAS No. 6533-68-2) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Mar; 445():1-277. PubMed ID: 12594530
[TBL] [Abstract][Full Text] [Related]
17. [Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents].
Veremko LN; Telegin LIu; Pevnitskii LA
Biull Eksp Biol Med; 1983 May; 95(5):73-5. PubMed ID: 6405824
[TBL] [Abstract][Full Text] [Related]
18. [Effect of chemotherapy on human tumor heterografts and lymphocytes in athymic mice].
Bukharova IK; Osokina LI; Milovanova TI
Biull Eksp Biol Med; 1987 May; 103(5):610-3. PubMed ID: 3593937
[TBL] [Abstract][Full Text] [Related]
19. [Experimental use of antitumor preparations in low doses].
Garkavi LKh; Kvakina EB; Mulatova AK; Taras'iants FM
Vopr Onkol; 1981; 27(7):61-6. PubMed ID: 6791380
[TBL] [Abstract][Full Text] [Related]
20. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
Friedman HS; Colvin OM; Skapek SX; Ludeman SM; Elion GB; Schold SC; Jacobsen PF; Muhlbaier LH; Bigner DD
Cancer Res; 1988 Aug; 48(15):4189-95. PubMed ID: 3390813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
